A phase 1/2 trial of Oxaliplatin(L-OHP) + S-1 in patients with previously untreated advanced colorectal cancer

ABSTRACT: Intervention name : Oxaliplatin | Tegafur-Gimeracil-Oteracil potassium capsule Dosage And administration of the intervention : Oxaliptatin:Infusion, Tegafur-Gimeracil-Oteracil potassium capsule:Oral Primary outcome(s): To determine RD,calculate response rate at the RD Study Design: Open-label,multicenter trial

DISEASE(S): Colorectal Cancer

PROVIDER: 2609918 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR